This page contains a Flash digital edition of a book.
»


DRUG DELIVERY


»


Key Targeting Approaches for Pharmaceutical Drug Delivery


Dev Prasad1 Harsh Chauhan, Ph.D.2


1Massachusetts College of Pharmacy and Health Sciences 2Creighton University


Drug targeting is defined as the ability of a drug molecule to accumulate in the target organ or tissue selectively such that the concentration of the drug at the disease site is high, while its concentration in non- target organs and tissues is low, preferably, below certain minimal level so as to prevent any toxic effect. Thus, drug targeting can overcome the non-specific toxic effect of conventional drug delivery. This may also reduce the amount of drug required to dose. A drug can be targeted on the level of a whole organ, on the level of certain cells specific for a given organ, or even on the sub-cellular level of specific tissue [1]. The concept of drug targeting was first mentioned by Paul Ehrlich when he suggested the hypothetical “magic bullet” as an entity consisting of two components — the first one should recognize and bind the target, while the second should provide a therapeutic action in this target. Currently, the concept of ‘magic bullet’ includes a coordinated behavior of three components – drug, targeting moiety and pharmaceutical carrier [2].


Various pharmaceutical carriers explored for targeting drug include polymeric micelles, liposomes, nanoparticles such as solid lipid nanoparticles, gold nanoparticles, quantum dots, etc. All these carriers can be made targeted in one way or another. The most widely-used approach involves utilizing specific targeting moieties. However in certain cases, physical principles or some physiological features of the target area may be utilized for a successful targeting of pharmaceuticals and pharmaceutical carriers. [1-3]


This article highlights approaches for drug targeting. Direct Application


Direct application of a drug into the affected area qualifies as a drug targeting approach as a high concentration of drug is achieved in the target area. Direct application may sound like a simple technique to achieve drug targeting, however developing such formulations can be complicated. The successful example of this approach includes intra-articulate administration of methotrexate liposomal preparations containing a phospholipid conjugate of methotrexate and dimyristoylphosphatidylethanolamine (MTX-γ-DMPE) for the treatment of arthritis [4]. Ophthalmic delivery of carteolol loaded


64 | | September/October 2013 - 15TH ANNIVERSARY ISSUE


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156